Patents Assigned to Noviscens AB
  • Patent number: 9044549
    Abstract: A syringe dispenser may include a plunger having an outer threading, a barrel adapted to contain liquid or semisolid fluid or any other material to be dispensed and to receive the plunger, the plunger being movably attached to the barrel, and a nut having an inner threading. The nut may at least partly enclose the plunger and the barrel, such that the inner threading of the nut engages with the outer threading of the plunger. A stand, an application plate, and a method of dispensing a controlled and measurable amount of liquid or semisolid fluid from a syringe dispenser are also disclosed.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: June 2, 2015
    Assignee: NOVISCENS AB
    Inventor: Bo Niklasson
  • Publication number: 20130043282
    Abstract: A syringe dispenser may include a plunger having an outer threading, a barrel adapted to contain liquid or semisolid fluid or any other material to be dispensed and to receive the plunger, the plunger being movably attached to the barrel, and a nut having an inner threading. The nut may at least partly enclose the plunger and the barrel, such that the inner threading of the nut engages with the outer threading of the plunger. A stand, an application plate, and a method of dispensing a controlled and measurable amount of liquid or semisolid fluid from a syringe dispenser are also disclosed.
    Type: Application
    Filed: April 19, 2011
    Publication date: February 21, 2013
    Applicant: NOVISCENS AB
    Inventor: Bo Niklasson
  • Patent number: 6562802
    Abstract: A composition is described, which comprises a cationic, hydrophilic, amine containing cationic derivatives of native chitosan; bound to an anionic scavenger substance, which is either (a) selected from the group consisting of anionic ethylene amine compounds, tetraazacycloalkane-N,N,N,N-tetraacetic acids; and polymer derivatives of porphyrines, or, (b) in the case of use in an UV radiation absorbing formulation, an antiviral, antifungal or anti-inflammatory formulation, an endogenous compound wherein cationic derivatives of native chitosan are not covalently bound to DTPA or EDTA; the amount of EDTA exceeds 0.5 wight percent; and taurine and taurine derivatives are not present.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: May 13, 2003
    Assignee: Noviscens AB
    Inventors: Benny Johansson, Bo Niklasson